Newsletter
Episode 4: Understanding Cystic Fibrosis

On the Pulse

Episode 4: Understanding Cystic Fibrosis

Cystic Fibrosis used to be considered a childhood terminal disease, but with research and improved treatments, the future continues to get brighter for those with CF. This month, Assistant Professor…
June 15, 2021

Episode 4: Understanding Cystic Fibrosis

Cystic Fibrosis used to be considered a childhood terminal disease, but with research and improved treatments, the future continues to get brighter for those with CF. This month, Assistant Professor Sarah Allgood joins the podcast to discuss cystic fibrosis causes, treatment, how people manage symptoms, and the future of CF care.

Dr. Allgood is a researcher who focuses on the role of pain and other symptoms in clinical outcomes among individuals with cystic fibrosis. Her long-term research goals include the development of interventions to help manage symptoms, especially in those with advanced lung disease.

Podcast References:

The Association Between Pain and Clinical Outcomes in Adolescents With Cystic Fibrosis

Cystic Fibrosis in the Year 2020: A Disease With a New Face

Descriptions of the Pain Experience in Adults and Adolescents with Cystic Fibrosis

Cystic Fibrosis Foundation

Continue the Conversation

@JHUNursing

@MonaShattell

Sarah Allgood

On the Pulse

Blog

Facebook Live

Podcasts

You may also like

Top Health Podcasts. Delivered to Your Inbox and Eardrums.

Join Our Newsletter

Proudly supported by:

cover
A Diverse Skill Set Peter McCanna is chief executive officer (CEO) at Baylor Scott & White Health, the largest not- for-profit health system in Texas. Through 51 hospitals and more than 1,200 access points, including flagship academic medical centers in Dallas, Fort Worth and Temple, the system offers the full continuum of care, from primary to award-winning specialty care, as well as an array of virtual and in-home services.